Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fang-Shu Ou"'
Autor:
Robert J. Mayer, Donna Niedzwiecki, Sui Zhang, Alexander Hantel, Eric G. Wolfe, Shuji Ogino, Al B. Benson, Leonard B. Saltz, Daniel Atienza, Chao Ma, Michael J. Messino, Alan P. Venook, Rex B. Mowat, Hedy L. Kindler, Seohyuk Lee, Charles S. Fuchs, Cary P. Gross, Fang-Shu Ou, Melinda L. Irwin, Jeffrey A. Meyerhardt, Renaud Whittom
Publikováno v:
JNCI Cancer Spectrum
Background Disparities in colon cancer outcomes have been reported across race and socioeconomic status, which may reflect, in part, access to care. We sought to assess the influences of race and median household income (MHI) on outcomes among colon
Autor:
Benson Al Bowen, Bert H. O'Neil, Alan P. Venook, Blase N. Polite, Robert J. Mayer, Sui Zhang, Michael Pollak, Eileen M. O'Reilly, James Edward Shaw, Charles D. Blanke, Donna Niedzwiecki, Brian C. Mullen, Fang-Shu Ou, James N. Atkins, Jeffrey A. Meyerhardt, Charles S. Fuchs, Heinz-Josef Lenz, Justin C. Brown, Andrew B. Nixon, Richard M. Goldberg, Federico Innocenti, Brendan J. Guercio
Publikováno v:
JNCI Cancer Spectrum
Background Energy balance-related biomarkers are associated with risk and prognosis of various malignancies. Their relationship to survival in metastatic colorectal cancer (mCRC) requires further study. Methods Baseline plasma insulin-like growth fac
Autor:
Sui Zhang, Charles D. Blanke, Justin C. Brown, Robert J. Mayer, James N. Atkins, Donna Niedzwiecki, James Edward Shaw, Federico Innocenti, Brian C. Mullen, Heinz-Josef Lenz, Jeffrey A. Meyerhardt, Fang-Shu Ou, Charles S. Fuchs, Blase N. Polite, Bert H. O'Neil, Alan P. Venook, Howard S. Hochster, Richard M. Goldberg, Eileen M. O'Reilly, Brendan J. Guercio
Publikováno v:
JNCI Cancer Spectrum
BackgroundIn nonmetastatic colorectal cancer, overweight and mild-to-moderately obese patients experience improved outcomes compared with other patients. Obesity’s influence on advanced or metastatic colorectal cancer (mCRC) is relatively unexplore
Autor:
Heinz-Josef Lenz, Blase N. Polite, Donna Niedzwiecki, Crystal S. Denlinger, Justin C. Brown, Robert J. Mayer, Sui Zhang, Jeffrey A. Meyerhardt, Fang-Shu Ou, Bert H. O'Neil, Alan P. Venook, Kimmie Ng, Federico Innocenti, Eileen M. O'Reilly, Richard M. Goldberg, Charles D. Blanke, James N. Atkins, James E. Shaw, Charles S. Fuchs
Publikováno v:
JNCI Cancer Spectrum
Background Diabetes is a prognostic factor for some malignancies, but its association with outcome in patients with advanced or metastatic colorectal cancer (CRC) is less clear. Methods This cohort study was nested within a randomized trial of first-